11.7C: Clonal Selection of Antibody-Producing Cells
- Page ID
The clonal selection hypothesis is a widely accepted model for the immune system’s response to infection.
- Describe the clonal selection hypothesis in regards to the production of B cells
- In 1954, immunologist Niels Jerne put forth the hypothesis that there is already a vast array of lymphocytes in the body before infection. The entrance of an antigen into the body results in the selection of only one type of lymphocyte to match it and produce a corresponding antibody to destroy it.
- B cells exist as clones derived from a particular cell. Thus the antibodies and their differentiated progenies can recognize and/or bind the same specific surface components composed of biological macromolecules of a given antigen. Clonality has important consequences for immunogenic memory.
- The clonal selection hypothesis states that an individual B cell expresses receptors specific to the distinct antigen, determined before the antibody ever encounters the antigen.
- clonal selection: An hypothesis which states that an individual lymphocyte (specifically, a B cell) expresses receptors specific to the distinct antigen, determined before the antibody ever encounters the antigen. Binding of Ag to a cell activates the cell, causing a proliferation of clone daughter cells.
- clone: A group of identical cells derived from a single cell.
The clonal selection hypothesis has become a widely accepted model for how the immune system responds to infection and how certain types of B and T lymphocytes are selected for destruction of specific antigens invading the body.
Four predictions of the clonal selection hypothesis
- Each lymphocyte bears a single type of receptor with a unique specificity (by V(D)J recombination).
- Receptor occupation is required for cell activation.
- The differentiated effector cells derived from an activated lymphocyte will bear receptors of identical specificity as the parental cell.
- Those lymphocytes bearing receptors for self molecules will be deleted at an early stage.
In 1954, Danish immunologist Niels Jerne put forward a hypothesis which stated that there is already a vast array of lymphocytes in the body prior to any infection. The entrance of an antigen into the body results in the selection of only one type of lymphocyte to match it and produce a corresponding antibody to destroy the antigen. This selection of only one type of lymphocyte results in it being cloned or reproduced by the body extensively to ensure there are enough antibodies produced to inhibit and prevent infection. Australian immunologist Frank Macfarlane Burnet, with input from David W. Talmage, worked on this model and was the first to name it “clonal selection theory. ” Burnet explained immunological memory as the cloning of two types of lymphocyte. One clone acts immediately to combat infection whilst the other is longer lasting, remaining in the immune system for a long time, which results in immunity to that antigen. In 1958, Sir Gustav Nossal and Joshua Lederberg showed that one B cell always produces only one antibody, which was the first evidence for clonal selection theory.
B cells exist as clones. All B cells derive from a particular cell, and as such, the antibodies and their differentiated progenies can recognize and/or bind the same specific surface components composed of biological macromolecules ( epitope ) of a given antigen. Such clonality has important consequences, as immunogenic memory relies on it. The great diversity in immune response comes about due to the up to 109 clones with specificities for recognizing different antigens. Upon encountering its specific antigen, a single B cell, or a clone of cells with shared specificity, divides to produce many B cells. Most of such B cells differentiate into plasma cells that secrete antibodies into blood that bind the same epitope that elicited proliferation in the first place. A small minority survives as memory cells that can recognize only the same epitope. However, with each cycle, the number of surviving memory cells increases. The increase is accompanied by affinity maturation which induces the survival of B cells that bind to the particular antigen with high affinity. This subsequent amplification with improved specificity of immune response is known as secondary immune response. B cells that have not been activated by antigen are known as naive lymphocytes; those that have met their antigen, become activated, and have differentiated further into fully functional lymphocytes are known as effector B lymphocytes.